Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Specimens From Normal Controls

This study has been completed.
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00341211
First received: June 19, 2006
Last updated: January 24, 2017
Last verified: December 1, 2010
  Purpose
The Viral Epidemiology Branch (VEB) of the National Cancer Institute (NCI) conducts research on viral infections and their associations with various diseases including AIDS and cancer. For some research questions, specimens are available from "case" subjects as part of ongoing protocols but are not available from normal "control" subjects (i.e., those without the infection or disease under study) to whom the case subjects can be compared. This protocol is to obtain routine specimens (usually peripheral venous blood, occasionally other body fluid such as saliva, urine, or tears) from healthy volunteers.

Condition
Viral Infections

Study Type: Observational
Official Title: Specimens From Normal Controls

Further study details as provided by National Institutes of Health Clinical Center (CC):

Enrollment: 27
Study Start Date: April 11, 1996
Estimated Study Completion Date: December 1, 2010
Detailed Description:
The Viral Epidemiology Branch (VEB) of the National Cancer Institute (NCI) conducts research on viral infections and their associations with various diseases including AIDS and cancer. For some research questions, specimens are available from "case" subjects as part of ongoing protocols but are not available from normal "control" subjects (i.e., those without the infection or disease under study) to whom the case subjects can be compared. This protocol is to obtain routine specimens (usually peripheral venous blood, occasionally other body fluid such as saliva, urine, or tears) from healthy volunteers.
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria
  • INCLUSION CRITERIA:

Subjects can be friends of VEB investigator or collaborator, hospital or office workers, repeat volunteer blood donors, etc.

EXCLUSION CRITERIA:

Must not be minors, prisoners, pregnant women or incapable of providing informed consent.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00341211

Locations
United States, Maryland
National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
National Cancer Institute (NCI)
  More Information

ClinicalTrials.gov Identifier: NCT00341211     History of Changes
Other Study ID Numbers: 999996013
OH96-C-N013
Study First Received: June 19, 2006
Last Updated: January 24, 2017

Keywords provided by National Institutes of Health Clinical Center (CC):
AIDS
Cancer
Epidemiology
Immunology
Virology

Additional relevant MeSH terms:
Virus Diseases

ClinicalTrials.gov processed this record on April 28, 2017